The company has developed novel, small molecule, carbohydrate-based therapeutics that generate efficacious anti-tumor cell-mediated immune responses, and its therapies and vaccines act against existing cancers in patients, through active immune strategies which utilize the patient's own immune defenses to target a large number of cancers, enabling physicians to treat in an enhanced way.